Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma

W.A.A. Tjalma

doi:10.12892/ejgo3363.2016

Article Menu

Export Article

Article Data

Views 2251
Dowloads 143

Letters to the Editor

Open Access

Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma

W.A.A. Tjalma^1,*,

¹ Department of Obstetrics and Gynecology, Antwerp University Hospital - University of Antwerp, Edegem, Belgium

DOI: 10.12892/ejgo3363.2016 Vol.37,Issue 1,February 2016 pp.5-5

Published: 10 February 2016

*Corresponding Author(s): W.A.A. Tjalma E-mail: Wiebren.Tjalma@uza.be

PDF (80.33 kB) View Full-text

Cite and Share

W.a.a. Tjalma. Staging classification for cancer of the ovary and the fallopian tube should include in situ carcinoma. European Journal of Gynaecological Oncology. 2016; 37(1): 5-5. doi: 10.12892/ejgo3363.2016

URL:

https://www.ejgo.net/articles/10.12892/ejgo3363.2016

References

[1] Prat J., FIGO Committee on Gynecologic Oncology: “Staging classification for cancer of the ovary, fallopian tube, and peritoneum”. Int. J. Gynaecol. Obstet., 2014, 124, 1.

[2] Mutch DG, Prat J. 2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer. Gynecol. Oncol., 2014, 133, 401.

[3] Prat J., FIGO Committee on Gynecologic Oncology: “FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication”. J. Gynecol. Oncol., 2015, 26, 87.

[4] Prat J., FIGO Committee on Gynecologic Oncology: “Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2015, 188, 133.

[5] Prat J., FIGO Committee on Gynecologic Oncology: “Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum”. Eur. J. Gynaecol. Oncol., 2015, 36, 367.

[6] Prat J., FIGO Committee on Gynecologic Oncology: “Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication of Guidelines From the International Federation of Gynecology and Obstetrics (FIGO)”. Obstet. Gynecol., 2015, 126, 171.

[7] Prat J., FIGO Committee on Gynecologic Oncology: “Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum”. Cancer, 2015, 121, 3452.

[8] Prat J.: “Ovarian, fallopian tube and peritoneal cancer staging: Rationale and explanation of new FIGO staging 2013”. Best. Pract. Res. Clin. Obstet. Gynaecol., 2015, 29, 858.

[9] Inoue K., Tsubamoto H., Hao H., Tamura K., Hashimoto-Tamaoki T.: “Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: a case report”. Gynecol. Oncol. Case Rep., 2013, 5, 61.

[10] Leeper K., Garcia R., Swisher E., Goff B., Greer B., Paley P.: “Pathologic findings in prophylactic oophorectomy specimens in high-risk women”. Gynecol. Oncol., 2002, 87, 52.

[11] Callahan M.J., Crum C.P., Medeiros F., Kindelberger D.W., Elvin J.A., Garber J.E., et al.: “Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction”. J. Clin. Oncol., 2007, 25, 3985.